AAX Biotech Takes Home the Nordic Star Pitch Competition at NLSDays 2026
AAX Biotech was selected as the winner of the ๐ก๐ผ๐ฟ๐ฑ๐ถ๐ฐ ๐ฆ๐๐ฎ๐ฟ ๐ฎ๐ฌ๐ฎ๐ฒ ๐ฃ๐ถ๐๐ฐ๐ต ๐๐ผ๐บ๐ฝ๐ฒ๐๐ถ๐๐ถ๐ผ๐ป ๐ช๐ถ๐ป๐ป๐ฒ๐ฟ at NLSDays 2026, held in Stockholm on September 8โ9 2026.
Our CEO/CSO Daniel X. Johansson pitched in a field of 13 other Nordic SMEs that represent the cutting edge of life science, from groundbreaking medical devices to life-saving therapeutics.
In the end, Daniel convinced the jury of seasoned investors of AAX Biotechโs technologies, Opti-mAbยฎ and Seqitopeยฎ, and their market potential.
The jury awarded the prize to AAX Biotech for โa highly sophisticated, high impact solution with a clear business caseโ.
You can read more on the Nordic Star Pitch Competition and NLSDays in their press release.